[Featured Stock] Microdigital Rises on Spotlight of Infectious Disease Testing Diagnostic Technology
[Asia Economy Reporter Yoo Hyun-seok] Microdigital is on the rise. It is interpreted that the upward trend of companies related to the novel coronavirus infection (COVID-19) is having an impact.
As of 9:26 AM on the 11th, Microdigital was trading at 17,600 KRW, up 6.67% (1,100 KRW) compared to the previous trading day.
Microdigital is a company listed on KOSDAQ as a technology-specialized company in June 2019. Based on optical and engineering technologies, it expanded its technology to biomarkers (diagnostic reagents) and entered the precision medical market. Its main business areas include the 3rd generation precision POCT system, automated immunoassay system, and bioanalysis system.
In particular, Microdigital owns a fully automated immunodiagnostic system (diamond) capable of diagnosing 80 people simultaneously. This system can perform optical measurement of samples and reagents with the push of a button. It can be applied not only to COVID-19 but also to various viruses.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If a Samsung Electronics Employee with a 100 Million Won Salary Receives a 600 Million Won Performance Bonus, Taxes Total 247.19 Million Won
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "White House Blocks Repatriation of 'Ebola-Infected' Doctor... Ultimately Transferred to Germany"
- "4.15 Million Won Prada Jacket Shows White Spots After One Wear"...Korea Consumer Agency Orders Full Refund
Additionally, Microdigital holds a patent for a cell culture system necessary for the development of biopharmaceuticals. The company has been carrying out a bio-pharmaceutical cell culture system development project under the Future Industry Leading Technology Development Program from June 1, 2015, to the end of May (for 5 years).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
